Inner Banner

International 2026

breadCrumb

Submitted by admin on Wed, 11/19/2025 - 21:12
Type
common
  1. Ahmad S, Butle A, Karn A, Sunder R, Mishra R, Bawaskar B, Parab P, Raje V, Chaubal R, Shet T, Kundu G, Gupta S, Dutt A (2026). CDKN1B inactivation impacts ER signaling and drives resistance to endocrine therapy in breast cancer. British Journal of Cancer. PMID: 42020778.

  2. Anand A, Dilip TR, Bhandare M, Chopde A, Patil S, Shrikhande SV (2026). Financial toxicity among gastric and pancreatic cancer Survivors in India and its impact on quality of life. Journal of Cancer Policy. 48:100730. PMID: 41780880

  3. Anand KV, Mishra GA, Suryawanshi VB, Pimple SA, Kulkarni VY, Vahabi M. Experiences with HPV self-sampling in India: advancing cervical cancer prevention and screening. BMC Public Health. 19;26(1):999.

  4. Archana CC, Saha S, Ojha S, Khattry N, Punatar S, Gokarn A, Chichra A, Mirgh S, Bain G, Mathew L, Tirlotkar A (2026). Isoagglutinin dynamics and transfusion dependency after ABO-incompatible haematopoietic stem cell transplants. Transfusion Medicine. PMID: 42082351

  5. Agate S, Patil S, Sarade M, Lokhande D, Bhojane S, Angane S, Das D, Banavali S, Chaturvedi P, Budukh A (2026). Overall survival of oral cancer from the population-based cancer registries of the Konkan area, Maharashtra, India. BMC Cancer.

  6. Agrawal N, Narasimhan M, Mojidra R, Bagal B, Khattry N, Gokarn A, Punattar S, Govekar R (2026). Reduced levels of ITGB1 cause activation of p38MAPK-ERK-LYN axis of BCR::ABL1 signaling despite inactivation of the oncoprotein by imatinib - novel resistance mechanism in blast crisis of chronic myeloid leukemia unraveled. Cell Communication and Signaling.

  7. Agrawal N, Narasimhan M, Mojidra R, Bagal B, Khattry N, Gokarn A, Punattar S, Govekar R (2026). Reduced levels of ITGB1 cause activation of p38MAPK-ERK-LYN axis of BCR::ABL1 signaling despite inactivation of the oncoprotein by imatinib - novel resistance mechanism in blast crisis of chronic myeloid leukemia unraveled. Cell Communication and Signaling.

  8. Bentzen S, Gupta T, Jacinto A, Rosenblatt E, Bhasker S, Napoles M, Binia S, Chansilpa Y, Aguiar S, Nagarajan M, Ghosh Laskar S, Marchi P, Goloubeva O, Hopkins K, Zubizarreta E, Agarwal J, Abdel-Wahab M (2026). Hypofractionated versus normofractionated accelerated radiation therapy with or without cisplatin for locally advanced head and neck squamous cell carcinoma (HYPNO): A randomized, open-label, Phase 3, noninferiority trial. International Journal of Radiation Oncology,Biology,Physic

  9. Broechner A, Rehné Jensen L, Juratli TA, Maier AD, Torp SH,....Moliterno J, Prat Acin R... Jensen RL, Gupta T, Patel AJ...etal (2026). Increased risk of early recurrence after gross-total resection in males with a WHO grade II meningioma: the impact of sex on recurrence and death in 5441 meningioma patients. Journal of Neurosurgery.

  10. Banerjee A, Mishra SV, Dsouza CA, Salunkhe S, Chandrani P, Dutt S (2026) Discovery of BEND4 as a novel single-gene prognostic marker and therapeutic target for adverse AML. NPJ Precision Oncology.

  11. Bamane V, Thakre S, Dhanawat A, Chepuri G, Joshi A, Gota V, Krishnamurthy MN. Idiopathic Bell's palsy in a patient With metastatic lung adenocarcinoma receiving nab-paclitaxel and pregabalin: A rare clinical observation. Case Reports in Oncological Medicine.

  12. Beadle BM, Benzerdjeb N, Cho J, Costes-Martineau V, Faquin WC, Gomez RS, Gupta R, Kholová I, Nagao T, Rane SU, Rito M, Thompson LDR, Samra S, Luk PP, Chiosea SI (2026). International consensus guidelines for diagnostic criteria and checklist for future studies for minimally invasive carcinoma ex pleomorphic adenoma: An HN CLEAR initiative. Head Neck Pathology. 20(1):33

  13. Baderiya D, Kothari A, Deshpande AD, Vidya R, Bipte S, Yadav SK, Sharma DB, Sharma D, Jha C, Kumar C, Hoysal DR, Agarwal G, Agrawal S, Devanhalli V. (2026). Evaluation of Surgeons' Perspectives and Perceived Readiness to Adopt Minimally Invasive Breast Surgery in a Low- and Middle-Income Setting. World Journal of Surgery. PMID: 42311108

  14. Balaji K, Ghogale SG, Deshpande N, Patil J, Girase K, Poojary S, Chatterjee G, Rajpal S, Patkar N, Epari S, Shet T, Gujral S, Subramanian PG, Tembhare PR (2026). Utility of multiparametric flow cytometry in the diagnosis and staging of Classic Hodgkin lymphoma-Experience in real-world practice. Cytometry Part B: Clinical Cytometry.

  15. Bancroft E, Page E, McHugh J.......Greenhalgh L, Murthy V...etal. (on behalf of the IMPACT Study Collaborators ) , Brook M, Kate-Zarai Z, Eles R (2026). Targeted prostate cancer screening in carriers of BRCA1 or BRCA2 pathogenic germline variants detects clinically relevant disease: 5-year results from the IMPACT study. European Urology.

  16. Begum SN, Hasan SK (2026). Prime editing driven functional genomics: Bridging genotype to phenotype in the post-genomic era. International Journal of Molecular Sciences. 27(4):1703. PMID: 41751840

  17. Bhandare MS (2026). Structured adaptability in HPB cancer surgery: Precision beyond technical uniformity. Annals of Surgical Oncology. PMID: 42120694

  18. Bhandari N, Devi YG, Acharya D, Bhat V, Chatterjee A, Yalshetti S, Arandkar S, Chaube BK, Shukla S (2026). MRPL47 deficiency drives mitochondrial dysfunction via ROS-p38-p21 signaling in non-small cell lung cancer.Journal of Biological Chemistry. 302(2):111058PMID: 41407038

  19. Bhat M, Narasimhan M, Shelar A, Patwardhan R, Sandur SK, Govekar R (2026). p38 MAPK-mediated suppression of Nrf2-MPC2 axis drives metabolic reprogramming which confers imatinib resistance in blast crisis phase of chronic myeloid leukemia. Experimental Cell Research. 455(2):114870. PMID: 41423144

  20. Bhandare MS, Nandy K, Parray AM, Pawar A, Padhy A, Menon V, Chopde A, Chaudhari V, Shrikhande SV (2026). Interplay of Post-Pancreatectomy Acute Pancreatitis, Postoperative Pancreatic Fistula, and Mortality after Pancreatoduodenectomy: Insights from a Comprehensive Cohort Study of 1594 Patients and Development of Predictive Nomograms. Journal of the American College of Surgeons.

  21. Chavda R, Rane SU, Mittal N, Gawde J, Rai D, Mahajan K, Sharma M, Pimple S, Mahimkar MB( 2026). Integrated clinical, histopathological, and inflammatory parameters for predicting malignant transformation in high-risk oral potentially malignant disorders: A prospective study. Head Neck Pathology. 20(1):32

  22. Crowell C, Mankuzhy NP, Bennett J, Bandopadhayay P... Gupta T, Chatterjee A, Epari S, Chinnaswamy G, Prasad M...etal..., Jabado N, Erker C (2026). Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-mutant: An International Multi-Institutional Study. Clinical Cancer Research.

  23. Chakrabarty N, Dadlani T, Mahajan A, Laskar SG, Nair D, Menon M, Rane S, Rane P, Deshmukh A, Pantvaidya G, Singh A, Sahu A, Patil A, Noronha V, Prabhash K, Chaturvedi P (2026). Diagnostic value of MRI-based iENE assessment for predicting major and minor extranodal extension in oral tongue carcinoma. Oral Oncology. 177:107960.PMID: 41936285

  24. Chakrabarty N, Krishnan N, Mahajan A, Dadlani T, Shah M, Deshmukh A, Singh A, Laskar SG, Pantvaidya G, Shetake A, Rane SU, Bal M, Nair D, Nair SV, Menon N, Patil A, Noronha V, Prabhash K, Chaturvedi P (2026). MRI-based tumor signatures as prognostic biomarkers in oral tongue squamous cell carcinoma. Frontiers in Oncology. 216:1809223.PMID: 42057830

  25. Chopra S, Mittal P, Gupta A, Goda JS, Pai V, Kannan S, Menon S, Deodhar K, Jain J, Sawant S, Wairkar T, Sawant S, Thakkar P, Nookala M, Ghosh J, Rath S, Popat P, Rangarajan V, Gota V, Gupta S (2026). Chemoradiation and image-guided brachytherapy alone or in combination with protease inhibitor (Nelfinavir Mesylate) in stage III cervical cancer: Results from a phase III trial. JCO Oncology Advances.3 (1) e2500088

  26. Corbeau A, Spampinato S, Charnalia M, Ranjan N, Gupta S, Kannan S, Dora T, Engineer R, Maheshwari A, Mittal P, Jain J, Gupta A, Panda S, Ghosh J, Sawant P, de Boer S, Hoogeman M, Nout R, Chopra S (2026). Normal tissue complication probability models for gastrointestinal toxicity after adjuvant (chemo)radiotherapy for cervical cancer in the PARCER trial, Radiotherapy and Oncology. 218:111444. PMID: 41698508

  27. Chaudhari P, Bendale K, Bhere S, Puri A, Gera P, Rane S (2026). Sclerotherapy for aneurysmal bone cyst in canine. Veterinary Medicine and Science.12(4):e70999.

  28. Cigliola A, Dizman N, Mercinelli C, Zhu Y, Carlo MI, Psutka SP, Berg SA, Prakash G, Aragon-Ching JB, Oualla K, Linville LM, Nguyen CB, Yip W, Maiorano BA, Tateo V, Spiess PE, Pal SK, Necchi A. Impact of Age on Outcomes in Metastatic Non-Clear Cell Renal Cell Carcinoma: A Real-World TriNetX Analysis From the Global Society of Rare Genitourinary Tumors (GSRGT). Clinical Genitourinary Cancer. 24(8):102658

  29. Charnalia M, Ranjan N, Spampinato S, Nout R, Pötter R, Leeuw A, Kirchheiner K, Tanderup K, Chopra S (2026). Cumulative gastrointestinal adverse events in EMBRACE-I: comparative evaluation of CTCAE vs. MOSES methods in predicting the impact of incident vs. persistent adverse events on quality of life, Radiotherapy and Oncology.

  30. Chilukuri S, Sundar SC, Subramani V, Arjunan M, Raveendran V, Kamath R, Meena L, Guruvaiah A, Phurailatpam R, Selvaraj R, Chaudhari L, Kumaar V, Jain N, Tiwari M, Halsana P, Sharma D, Maitre P, Murthy V (2026). Pre-PROTO-PRIME study: Stereotactic body proton therapy to the prostate and pelvic nodes for high-risk and node-positive prostate cancer — feasibility, acute toxicity and dosimetric insights. Clinical and Translational Radiation Oncology.56:101084.

  31. Das D ,Tandale S, Budukh A(2026) PopMortGen-India: An excel based tool for preparing population mortality files from life tables for relative survival analysis for cancer patients from India. ecancer. 20:2082

  32. Das P, Das N, Narula G, Trehan A, Bakhshi S, Radhakrishnan V, Seth R, Tembhare P, Sachdeva MU, Chopra A, Sundersingh S, Das S, Gogoi M, Parihar M, Bhattacharya R, Banavali S, Saha V, Krishnan S (2026). Toxicity during induction of pulsed versus continuous prednisolone in children with acute lymphoblastic leukaemia: a multi-centre, open label, randomised, phase 3 trial from India (2016–2022). The Lancet Regional Health - Southeast Asia.

  33. Dey A, Swaminathan N, Grewal A (2026) . A Window to the Stomach-Gastric Ultrasound's Growing Role in Pediatric Anesthesia. Pediatric Anesthesia.

  34. Das A, Bisen V, Dhurandhar Y, Bodakhe SH, Varma AK, Misra G, Namdeo KP (2026). Clusterin in head and neck squamous cell carcinoma: Diagnostic, prognostic, and therapeutic implications. Current Oncology Reports. 28(1):68.PMID: 42319538

  35. Das D, Tambe M, Rajak J, D'Silva SZ (2026). Identification of the novel HLA-B*44:03:02:08 allele in an Individual from eastern India. HLA. 107(4):e70713.PMID: 42059315

  36. Das DK, Shivshankar S, Budukh AM, John D (2026). Association between pesticide use and cancer incidence among farm workers: a systematic review protocol. JBI Evidence Based Synthesis.PMID: 41636132

  37. Dasgupta A, Ghosh S, Chatterjee A, Kannan S, Goswami S, Ranjith CP, Punde R, Meena L, Shinde P, Konthoujam M, Phurailatpam R, Sutar A, Patil D, Sahu A, Sridhar E, Moiyadi A, Menon N, Puranik A, Bano N, Gupta T (2026). Proton versus photon radiotherapy in adults with primary brain tumors evaluating functional survival: a phase 3 randomized controlled trial study protocol (PRIDE). Radiation Oncology.21(1):38. PMID: 41689093

  38. Dey S, Anne S, Rath S, Nandhana R, Gulia S, Dash B, Menon S, Rekhi B, Baheti A, Sable N, Popat P, Tandon S, Ghosh K, Gurram L, Parab SS, Logkumer AN, Jhadhav S, Chopra S, Surappa ST, Bansal V, Balsarkar G, Deodhar K, Maheshwari A, Ghosh J, Gupta S (2026). Malignant ovarian germ cell tumor-survival and reproductive outcomes and patterns of relapse. Cancer Medicine. 15(6):e71936. PMID: 42210622

  39. Dutta D, Maity A, Gupta SK, Gera P, Jain H, Bagal B, Chatterjee G, Rajpal S, Nayak L, Punatar S, Bandyopadhyay S, Chakraborty A, Chendamarai E, Balasundaram N, Gota V, Khattry N, Sengar M, Mathews V, Hasan SK. Venetoclax induces mitochondrial apoptosis and autophagy to overcome arsenic trioxide resistance in acute promyelocytic leukemia. J Transl Med. 24(1):56. PMID: 41527127

  40. Dhar A, Siva S, Tan VS, Mahadevan A, Bruynzeel A, Tang C, Cury F, Corkum M, Ali M, Zaorsky NG, Cheung P, Hannan R, Hudes R, Morgan S, Lo S, Murthy V, Correa RJM, Swaminath A (2026). International Radiosurgery Oncology Consortium of the Kidney (IROCK) contouring guidelines for renal cell carcinoma treated with stereotactic ablative radiotherapy. International Journal of Radiation Oncology, Biology, Physics.

  41. Gohil D, Gandhi KA, Gupta SK, Gera P, Yadav S, Patwardhan R, Checker R, Sharma D, Khattry N, Sandur S, Gota V( 2026). Immunomodulation by juglone alleviates acute graft-versus-host disease without compromising the graft-versus-leukaemia activity in mice. British Journal of Pharmacology. 183(1):131-152.PMID: 38584000

  42. Gupta R, Fielder T, Bal M..........Chernock R...Kamboj M...Patil A...Rane S...etal. on the behalf of the HN-CLEAR steering committee and clinical advisory group (2026). International consensus recommendations and alignment of terminology for the histopathological diagnosis of extranodal extension in head and neck squamous cell carcinoma: an HN-CLEAR initiative. Lancet Oncology. 27(1):e33-e44.

  43. Gera P, Chavan P, Kamtalwar S, More A, Jadhav V, Parikh P, Haralkar S, Mohite R, Patil M, Samal R, Sarin R, Pagdhune A (2026). A Variant in the TSH β Gene Resulted in Discordant TSH Levels in an Indian Patient. The electronic Journal of the International Federation of Clinical Chemistry and Laboratory Medicine. 37(1):171-176.PMID: 41659285

  44. Ghag S, Jha AK, Konuparamban A, Puranik A, Rangarajan V(2026). A comparative analysis of OLINDA EXM 2.0 and MIRDcalc for Lu-177 DOTATATE radionuclide therapy, Radiation Physics and Chemistry. 245:113867.

  45. Gupta S, Rajendran A, Chichra A, Qureshi A. Simultaneous Presentation of Hemophagocytic Lymphohistiocytosis and Classical Hodgkin's Lymphoma in a Patient with Underlying Germline Homozygous STXBP2 Mutation. Mediterr J Hematol Infect Dis. 2026 May 1;18(1):e2026043. doi: 10.4084/MJHID.2026.043. PMID: 42136900;

  46. Gupta T, Dasgupta A, Chatterjee A. Craniospinal irradiation plus tumor-bed boost with standard adjuvant chemotherapy OR high-dose chemotherapy plus autologous stem cell transplant as a radiation-sparing approach in WNT medulloblastoma of early childhood: Fire OR Ice? Journal of Neuro-oncology. 177(1): 33.PMID: 41790323

  47. Gupta T, Dasgupta A, Goswami S, Chatterjee A, Dhingra S, Deodhar J, Sonkusare L, Prasad M, Gollamudi VRM, Kannan S, Vishwakarma K, Menon N, Moiyadi A, Shetty P, Singh V, Epari S, Sahay A, Shah A, Sahu A, Choudhari A, Bhattacharya K, Bano N, Gupta N, Chinnaswamy G. Memantine to preserve memory and neurocognition following craniospinal irradiation (MEMENTO): a phase 3 randomized controlled trial. BMC Cancer. 26(1):365. PMID: 41673604

  48. George A, Nair S, Prabhash K, Thakur S, Gera P, Singh A, Chaturvedi P, Rane S, Pradhan T, Sen S, Barkume M, Shetty D, Chaubal K, Ghosh A, Kamte S, Kode J (2026). Generation and characterization of early stage oral cancer cell line of buccal mucosa of Indian origin. Human Cell. 39: 21.

  49. Guha A, Gawde J, Mahajan K, Bagal B, Parab A, Rajeshwari A, Shetty N, Kulkarni S (2026). Is looking at the tip of the iceberg sinking our ship? A longitudinal cohort study on the patterns of evolution on treatment of non-enhancing FLAIR lesions in primary CNS lymphoma. Journal of Neurooncology. 177(1):7

  50. Gupta A, Kanala TS, Shinde P, Joshi K, Mulani J, Prajapati K, Jain J, Mittal P, Chopra S (2026). Spatially fractionated radiotherapy as an alternative to brachytherapy for cervical cancer with unfavourable dosimetry: An in-silico study. Cancer Radiotherapy. 30(4):104878.

  51. Gupta S, Nair N, Hawaldar RW, Joshi S, Gulia S, Shet T, Sarin R, Parmar V, Desai S, Ghosh J, Wadasadawala T, Vanmali V, Panhale T, Parab P, Patil A, Chitkara G, Rath S, Bajpai J, Pathak R, Popat P, Thakur M, Badwe RA (2026). Addition of Carboplatin to Sequential Taxane-Anthracycline Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Phase III Randomized Controlled Trial. Journal of Clinical Oncology. 44(1):9-19. PMID: 41115255

  52. Iengar P, Venkatraman P (2026). Using the reactome graph database to generate pathway fingerprints for cancer-related genes, and using the fingerprints to gain insights into cancer, comorbidity, and cancer gene networks. Computational Biology and Chemistry. 120 Part 1: 108686.PMID: 41252800

  53. Inchanalkar M, Chavda R, Gawde J, Patil A, Kaushal RK, Mahimkar MB (2026). Upregulation of Derlin 3 (DERL3) protein expression is associated with Oral Cancer progression and is independent of promoter hypermethylation. BMC Cancer.

  54. Joshi P, Bhawalkar A, Singhavi H, Patil A, Thiagarajan S, Singh A, Shetty R, Gontu GSSR, Nair S, Chaturvedi P (2026). Utility of biopsy and frozen section in detecting malignancy within clinically suspicious verrucous growths: A retrospective study. International Journal of Oral and Maxillofacial Surgery.

  55. Janu AK, Rai P, Choudhari AJ, Gala K, Puri A, Pruthi M, Ramadwar M, Panjwani P, Nayak P, Pathak P, Chakrabarty N, Parambil BC, Khanna N, Laskar S, Shetty N, Kulkarni S. Comparison of FRACTURE MRI, Conventional Radiography, and CT in the Evaluation of Bone Tumors. Radiol Imaging Cancer. 2026 Jan;8(1):e240525. doi: 10.1148/rycan.240525. PMID: 41481491; PMCID: PMC12862464.

  56. Jeeva M, Gurav M, Chatterjee A, Shetty O, Bapat P, Dhingra S, Dasgupta A, Paul A, Chinnaswamy G, Prasad M, Moiyadi A, Shetty P, Sahay A, Shah A, Sahu A, Choudhari A, Guha A, Bhattacharya K, Epari S, Gupta T. H3K27M-altered diffuse midline glioma: Experience and outcomes from a low-middle income country setting in the contemporary era. Neuro-oncology Advances. 8(1):vdag112. PMID: 42180673

  57. Jose M, Sable S, Wadasadawala T, Sarin R, Pathak R, Krishnamurthy R, Joshi S, Shankhdhar V, Jaiswal D, Mathews S, Mantri M. Safety and early outcomes of immediate autologous breast reconstruction in advanced breast cancer: An Indian experience. European Journal of Breast Health. 22(3):285-293. PMID: 42316940

  58. Joshi P, Kole L, Shah SA, Singh A, Shetty R, Nair S, Chaturvedi P (2026). Assessing quality of life in oral cancer survivors: A cross-sectional study in India. Journal of Maxillofacial and Oral Surgery.

  59. Juneja A, Sahay A, Padwale P, Patil A, Pai T, Panjwani P, Joshi S, Wadasadawala T, Popat P, Shet TM, Gupta S, Desai SB (2026). Concordance of conventional two-tier HER2 classification versus three-tier classification (including HER2-low status) in invasive breast carcinoma: a retrospective real-world analysis. Journal of Clinical Pathology

  60. Kamal A, Sheregare Y, Patkar C, Markam M, Deolikar R, Sriraman N, Seth A, Jaiswal M, Khadilkar RJ (2026). Bendless-mediated K63 ubiquitination modulates cellular signalling to Cell Communication and Signaling regulate Drosophila hematopoiesis. Cell Communication and Signaling.PMID: 42015212

  61. Kamran S, Mahmood H, Chopra S, Chatterjee S, Ooi KY, Zaid RM, Chitapanarux I, Nuryadi E, Gondhowiardjo S, Kawamura M, Chang JH, Minjgee M, Bayasgalan U, Faheem M, Fatima H. Mapping Breast Cancer Care Patterns in FARO Member Countries: A Survey. Journal of Cancer Policy. PMID: 42379516

  62. Kashid SR, Budrukkar A, Swain M, Laskar SG, Murthy V, Gupta T, Sasidharan A, Patil V, Joshi A, Noronha V, Mittal N, Mahimkar M, Patil A, Patel U, Sinha S, Kumar A, Menon N, Bal M, Prabhash K, Agarwal JP. Prognostic Factors in Oropharyngeal Cancer Treated With Definitive Chemoradiotherapy. Cancer Medicine.;15(5):e71854. .PMID: 42130118

  63. Kazi M, Saklani A, Kammar P, Desouza A, Sukumar V, Lavingia V, Mehta S, Bhatt A. Systematic total parietal peritonectomy for peritoneal mesothelioma-perioperative and oncological outcomes in an Indian cohort of 100 patients. European Journal of Surgical Oncology. 52(9):111978. PMID: 42379051

  64. Khanna D, Pentapati SSK, Sharma P, Shruti T, Vishawakarma R, Sharma A, Balasundaram P, Maurya NK, Maurya VK, Varma RK, Budukh A, Mishra G, Pradhan S, Chaturvedi P. Effectiveness of a capacity-building training for knowledge and practices of tobacco control and oral cancer prevention: a pre-post study from rural northern India. BMC Oral Health. PMID: 42374470.

  65. Krishnan A, Baviskar Y, Chatterjee A, Dasgupta A, Epari S, Sahu A, Chinnaswamy G, Menon N, Moiyadi A, Gupta T, Goda J (2026). Presentation and outcomes of CNS tumors associated with phakomatoses syndromes from a specialized Neuro-Oncology practice in India. Cancer Medicine.15(2):e71483. PMID: 41640172

  66. Kumar A, Gurav M, Sarkar J, Bapat P, Madhu K, Shetty O, Chatterjee A, Sahay A, Dasgupta A, Moiyadi A, Shetty P, Gupta T, Goda JS, Epari S (2026). Impact of IDH mutation and MGMT methylation as Independent prognostic markers in uniformly treated high grade glioma Patients: A Real-World evidence in the Indian Population. Brain Research. 1877-1878:150205.

  67. Krishnamurthy Manjunath N, Patil V, Shirsat A, Wairagade S, Pradosh A, Kumar S, Jadhav S, Chavan A, Patil A, Joshi A, Prabhash K, Gota V, Noronha V (2026). A prospective, open-label, randomized, crossover study to compare the pharmacokinetics of crushed methotrexate with that of the tablet formulation in patients with head-and-neck cancer. Cancer Research, Statistics and Treatment 9(1):1-7.

  68. Khan UK, Goel A, Nigam S, Chaudhary N, Praveen A, Roy A, Fatima F, Sawhney DK, Dalwai A, Shendre A, Carskadon S, Bajpai A, Kapoor A, Tewari A, Chandra A, Saklani A, Dalal SN, Palanisamy N, Ateeq B. DKC1 promotes colorectal cancer progression and therapy resistance by dysregulating sphingolipid biosynthesis. Nature Communications. 17(1):4406.

  69. Kumari A, Mal A, Thorat R, Saha P, Patel P, Valvi S, CM Krishna, De A, Bandyopadhyaya R (2026). Sustained and localized delivery of gemcitabine using chitosan-PVA-TPP polymeric implant enhances antitumor efficacy and delays surgical relapse in pancreatic cancer. Biomaterials Advances. 179: 214489. PMID: 40976113

  70. Kizhakethil RV, Varma AK, Bhogale OV, Joshi MA, Barage SH, Kumar AWS, Kamble SS (2026). Conformational dynamics and energetic perturbations in human β-spectrin-II mediated by calpain cleavage-related mutations: Insights from enhanced sampling simulations. Computational Biology and Chemistry.120(Pt 2):108759.PMID: 41192394.

  71. Kannan N, Achrekar A, Terse V, Gawde V, Joshi S, Bhanshe P, Chaudhary S, Salunke P, Ghogale S, Deshpande N, Shetty D, Shetty A, Mirgh S, Nayak L, Gokarn A, Punatar S, Jain H, Bagal B, Sengar M, Khattry N, Rajpal S, Chatterjee G, Tembhare P, Subramanian PG, Patkar N (2026). Acute myeloid leukaemia (AML) harbouring KMT2A-PTD: should it be considered as a myelodysplasia-related abnormality? Journal of Clinical Pathology.

  72. Karale B, Tambe M, Rajak J, D'Silva SZ (2026). Identification of the novel HLA-C*12:03:01:80 allele in an individual from Bihar. HLA. 107(3):e70656

  73. Karale B, Tambe M, Rajak J, D'Silva SZ (2026). Identification of the Novel HLA-B Allele, HLA-B*57:198, in an Individual From North India. HLA. 107(1):e70538

  74. Kazi M, Sharma A, Desouza A, Saklani A (2026). Watch and wait versus surgery for rectal cancer: Markov modeling derived thresholds for salvage, regrowth, and near-complete responders. Annals of Surgical Oncology.

  75. Mathen C, Dsouza W, Sharma D, Pradhan TN, Kesarwani A, Gujar D, Choudhary ML, Nithyanand A, Ghosalkar R, Ingle A, Chaudhari P, Goda JS, Kode J (2026). Preclinical efficacy and safety evaluation of a topical mesenchymal stem cell derived conditioned media gel for oral mucositis management. Scientific Reports.

  76. Malik S, Mahajan AA, Pillai SJ, Shinde I, Shameem M, Pande S, Chandrani P, Inamdar MM, Khadilkar RJ (2026). Developmental regulation of progenitor aging shapes long-term intestinal homeostasis in Drosophila. FEBS Letters.

  77. Malhotra R, Moitra P, Chatterjee A, Kota PK, Dasgupta A, Epari S, Menon N, Kowtal P, Sarin R, Gupta T (2026). Clinical and genetic predictors of temozolomide-induced severe myelotoxicity in adult diffuse glioma: a case-control study. Journal of Neurooncology. 177(1):9.

  78. Maniar J, Datt P, Dange PP, Kailaje V, Lakhera M, Samarth M, Durve T, Kadam A, Gandhi KA, Gupta S. Microenvironmental Cues That Regulate Cancer Cell Dormancy in Estrogen-Receptor Positive and Triple-Negative Breast Cancer Cell Lines. Cancer Medicine. 15(7):e72059. PMID: 42366462

  79. Maniar J, Dhas P, Datt P, Dange P, Gandhi KA, Bhatia D, Chaubal R, Gardi N, Kembhavi Y, Joshi S, Badwe R, Gupta S. Hypoxia-reoxygenation cycle leads to context dependent phenotypic effects in breast cancer cell lines. Molecular Biology Reports.;53(1):931.PMID: 42268356

  80. Mawalankar G, Achrekar A, Biswas S, Terse V, Joshi S, Ugale P, Bhanshe P, Chaudhary S, Kusurkar S, Shahin S, Gawde V, Shetty D, Jindal N, Mirgh S, Shetty A, Gokarn A, Punatar S, Nayak L, Jain H, Bagal B, Sengar M, Khattry N, Rajpal S, Chatterjee G, Tembhare P, Subramanian PG, Patkar N (2026). Validation and refinement of the European LeukemiaNet 2022 genetic risk stratification of AML. JCO Global Oncology.PMID: 41719508

  81. Mehrotra M, Chakraborty S, Saldanha E, Joshi D, Dhadve A, Sakpal A, Chandrani P, Maheshwari A, Menon S, Ghosh J, Gupta S, Ray P (2026). Alpelisib enhances cisplatin mediated cytotoxicity in non-mutated, PIK3CA-dependent high-grade serous ovarian cancer. Journal of Ovarian Research.PMID: 42332790.

  82. Mehta D, Paradkar A, Rekhi B, Nayak P, Mohanty B, Chaudhari P, Gera P, Rane S, Chaturvedi P, Waghmare SK (2026). Histone methylation defines c-Jun/Sox2/Hif1α axis that controls stemness and tumor progression in squamous cell carcinoma. Nature Communications. PMID: 42045185

  83. Mir MA, Bhat A, Macha MA, Mehraj U, Verma N, Masoodi G (2026). p53 in cancer therapy: the impact of mutations on the genome guardian. Frontiers in Immunology. PMID: 42051537

  84. Mirgh S, Goel A, Punatar S, Gokarn A, Jindal N, Chichra A, Nayak L, Bain G, Nashikkar C, Mahajan P, Deval K, Khan A, Tembhare P, Patkar N, Rajpal S, Chatterjee G, Kannan S, Mathew L, Subramanian P, Bagal B, Khattry N (2026). Is Less "Sufficient" and "Safe" in the MRD era - outcomes of autologous stem-cell transplant as per melphalan dose in patients with multiple myeloma. Blood Cancer Journal. 16(1):10.PMID: 41507137

  85. Mirian C, Jensen LR, Hoffmann AG, Juratli TA, Maier AD, Lindner P, Broechner A, Torp SH, Shih HA, Morshed RA, Young JS, Magill ST, Stummer W, Spille DC, Brokinkel B, Proescholdt M, Kuroi Y, Gousias K, Simon M, Prat-Acin R, Goutagny S, Wach J, Güresir E, Yamamoto J, Kim YZ, Lee JH, Kim DW, Koshy M, Cannon DM, Shrieve DC, Suh CO, Chang JH, Kamenova M, Straumann S, Soleman J, Eyüpoglu IY, Catalan T, Lui A, Theodosopoulos PV, McDermott MW, Góes P, Wang F, Souhami L, Guiot MC, Csonka T, Endo T, Gupta T, Patel AJ, Klisch TJ, Kim JW, Maiuri F, Barresi V, Tabernero MD, Skyrman S, Krause M, Law I, Kristensen BW, Munch TN, Meling T, Fugleholm K, Blanche P, Mathiesen T (2026). Fractionated radiotherapy adjuvant to surgery of WHO-2 meningioma with and without gross total resection: a multicenter, retrospective cohort study of 1,452 patients. Journal of Neuro-oncology. 176(3):201. PMID: 41661453

  86. Mirji G, Punatar S, Khattry N, Chiplunkar S (2026). Gamma delta T cell reconstitution in Acute Lymphoblastic Leukemia patients post allogenic HSCT predicts clinical outcome and overall survival, Transplant Immunology. 95:102358. PMID: 41651192

  87. Misra A, Phadte A, Subramani V, Dhanawat A, Menon S, Arora A, Nagarajan R, Maitre P, Pal M, Joshi A, Lila A, Prakash G, Murthy V. Contemporary management of adrenocortical carcinoma: A narrative review. Urol Oncol. 2026 May 12:S1078-1439(26)00217-6. doi: 10.1016/j.urolonc.2026.04.010. Epub ahead of print. PMID: 42120273.

  88. Mohanty P, Madaan P, Patkar N, Shetty D (2026). Myeloid/lymphoid neoplasm with FLT3 rearrangement. Journal of Hematology and Allied Sciences. 6:179-81.

  89. Mohite SU, Panse N, Kannan R, Tapkire R, Pradhan S, Gulia A, Mirgane K, Dhalgade S, Sangale V, Khandagale S, Kadir Laskar A, Das U, Dutta J, Chakraborty T, Pathak R, Krishnatreya M, Pahwa V, Kotkar L, Manjrekar A, Kadam K, George GS, Moirangthem R, Bharmal K, Doibale P, Ostwal V, Shrikhande SV, Kulkarni S, Shetty N, Dikshit R, Chaturvedi P, Mhatre S (2026). Prevalence of gallstone disease in India: insights from a community-based cross-sectional study. BMJ Public Health. 4(1):e004015. PMID: 41658223

  90. Murthy V, Maitre P, Priya S, Dhingra S, Dhanawat A, Shah M, Bhattacharya K, Adepu A, Singh P, Phurailatpam R, Patil D, Noronha V, Prabhash K, Misra A, Arora A, Pal M, Prakash G, Menon S, Joshi A (2026). Reduced length of ADT and ARTA with XRT in high-risk prostate cancer: A randomised controlled trial, Clinical Oncology.

  91.  

  92. Mittal P, J. Kamalnath, Charnalia M, Anjana AK, Jain J, Gupta A, Chopra S (2026). Point S (sigmoid) doses and correlation with late recto-sigmoid adverse events in patients undergoing image-based brachytherapy for cervical cancer: clinical outcomes. Brachytherapy.

  93. Mehrotra M, Shenoy P, Sakpal A, Chakraborty S, Ray P (2026). p53-R248W evades doxorubicin mediated cell death through collective alteration in TOP2A and CYP1A1 genes in cancer cells. Biochemical and Biophysical Research Communications.

  94. Murthy V, Maitre P, Pal M, Arora A, Phurailatpam R, Sharma R, Gudipudi D, Rajappa S, Pujari L, Bandekar B, Joseph D, Kannan S, Krishnatry R, Misra A, Joshi A, Noronha V, Prabhash K, Menon S, Bakshi G, Prakash G. Bladder Adjuvant Radiotherapy: Phase III Multicenter Randomized Controlled Trial of Adjuvant Radiotherapy or Observation for Postcystectomy Muscle-Invasive Bladder Cancer. J Clin Oncol. 2026 May 21:JCO2502093 Epub ahead of print. PMID: 42166701.

  95. Moirangthem R, Manjrekar A, Pullat GB, Golapkar SV, Margale RS, Sagare S, Talukdar D, Chakraborty N, Pathak R, Pradhan S, Krishnatreya M, Panse N, Dikshit R, Soerjomataram I, Gupta S, Mhatre S (2026). Association of chewing tobacco and the risk of breast cancer in Indian women: A multicentre case-control study. International Journal of Breast Cancer.

  96. Mirgh S, Sood K, Punatar S, Gokarn A, Chichra A, Nayak L, Bain G, Bagal B, Khattry N (2025). MRD-directed consolidation in multiple myeloma – Are we there yet? Clinical Lymphoma Myeloma and Leukemia.

  97. Mirian C, Jensen LR, Hoffmann AG, …… Bertero L, Stummer W, Spille DC, Brokinkel B, Oya S, Miyawaki S, Saito N, Proescholdt M… Gupta T, Patel AJ, Klisch TJ, Kim JW…etal (2026). Simpson Grading and Risk of Recurrence in 4074 Meningioma Patients With Gross Total Resection. Neurosurgery.

  98. Maitre P, Murthy V (2026). From constraints to confidence: A roadmap of 'Simple' SBRT for low-resource clinical environments. International Journal of Radiation Oncology,Biology,Physics. 124(5): 1175-1177.

  99. Meher R, Maharana J, Kavvuri J, K Nirmal Kumar, Pradhan T, Kailaje V, Ingle A, Sen S, Barkume M, Patkar M, Vaibhaw A, Mir SA, Ghosh A, Kamte S, Kamal A, Kode J (2026). A Phenstatin-based indole-chalcone hybrid as novel anti-inflammatory agent targeting the NLRP3 Inflammasome: Leads from computational and preclinical studies. Bioorganic Chemistry.170:109429.

  100. Naik K, Deshpande G, Bhandare M, Bhargava P, Rekhi B, Ramadwar M (2026). Gastric Synovial sarcoma: A case report and review of literature. International Journal of Surgical Pathology.

  101. Nagar A, Samanta A, Chopra S, Mittal P, Gupta A, Jain J, Ghadi Y, Panda S, Rane P, Sawant P, Rath S, Ghosh J, Gupta S. (2026)CT vs. MRI for image-guided brachytherapy in locally advanced cervical cancer: A Propensity Score Matched Analysis. International Journal of Radiation Oncology,Biology,Physics.PMID: 41692354

  102. Nath S, Hole A, Bagal B, Noothalapati H, Govekar R, CM Krishna (2026). Comparison of biological materials to assess their suitability for Raman spectroscopic detection of chronic myeloid leukemia. Analytical Methods. 18(8):1654-1666. PMID: 41664976

  103. Noguera NI, Hasan SK and Cicconi L (2026) Evaluating differentiation therapy and biomarkers in myeloid malignancies. Frontiers in Oncology. 16:1867602. PMID: 42222386

  104. Noronha V, Rao A, Pillai A, Ramaswamy A, Gota V, Mailankody S, Pushpam D, Sehgal A, Banerjee J, Kapoor A, Kumar A, Shah M, Menon N, Narasimhan P, Mahajan P, Timmanpyati S, Chitre A, Sonkusare L, Mahajan S, Daptardar A, Vagal M, Mishra BK, Anne S, Gupta T, Roy M, Shetty N, Kumar A, Mittal K, Mahajan V, Sharma S, Prabhash K. Guidelines for geriatric oncology in India: Recommendations for clinical practice (version 1). Journal of Geriatric Oncology.;17(7):103038.. PMID: 42379122

  105. Noronha V, Shah M, Kapoor A, Menon N, Patil V, Kurup AR, Dhar A, Goud S, More S, Yadav A, Agarwal A, Sable N, Chavan N, Pradosh A, Shirsat A, Gota V, Shetake A, Sharma S, Mishra BK, Gupta A, Sansar B, Sonawane S, Prabhash K (2026). Low-Dose Versus Standard-Dose Abiraterone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Multicenter Randomized Phase III Trial. JCO Global Oncology. 12(4):e2500505.PMID: 42024845

  106. Nair S, Shetty R, Bhawalkar A, Joshi P, Singh A, Singhavi H, Sharma JK, Sinha S, Kumar A, Laskar SG, Joshi A, Chaturvedi P (2026). Impact of infratemporal fossa clearance on survival in advanced buccal mucosa cancers. Head Neck.

  107. Nagare M, Sahoo M, Sengar M, Punatar S, Khattry N, Gokarn A, Bagal B, Jain H, Mirgh S, Epari S, Shet T, Pradhan T, Shirsat S, Barkume M, Mathen C, Gera P, Verma RK, Saldanha E, Chandrani P, Gawde J, Chiplunkar S, Kode J (2026). Defining alteration in bone marrow mesenchymal stem cells (MSC) from acute myeloid leukemia and exploring cultured MSC-conditioned media as a novel anti-leukemia therapy agent. Cancer Immunology Immunotherapy. 75(3):83.

  108. Oak A, Cheulkar S, K. Sivaranjini, John R, Jadhav M, Patil D, Dashmukhe E, Patil A, Wankhade S, Gode P, Thakadiyil A, Balasubramanium G, Mishra G, Dikshit R, Chaturvedi P, Gupta S (2026). Assessment of an EMR-integrated Onco-Insight hospital-based cancer registry system for data completeness and data entry turnaround time at a tertiary care cancer center in India. Frontiers in Oncology.16:1852225.PMID: 42344698

  109. Oswal K, Barman S, Kerr AR, Zaman M, Patowary J, Barali DD, Barman N, Das A, Nadkar U, Dikshit R, Gallagher JE, Lingen MW, Muwonge R, Castle PE, Cheung LC, Yu KJ, Chaturvedi AK, Purushotham A. Oral cancer risk stratification: A cross-sectional population-based screening study in Northeast India. International Journal of Cancer. 158(6):1517-1527. PMID: 40974103

  110. Ostwal V, Parulekar M, Naughane D, Ramaswamy A, Garkal T, John G, Mandavkar S, Bhargava P, Gupta A, Kapoor A, Joshi P, Shetty O, Srinivas S, Kannan S, Chaugule D, Jadhav P, Joshi A, Ghosh J, Noronha V, Menon N, Prabhash K, Khandare M, More S, Gaud S, Banavali S, Gupta S (2026). Carica papaya leaf extract to improve chemotherapy-induced thrombocytopenia: A phase III triple-blinded, randomized, placebo-controlled, multicentric trial. JCO Global Oncology.(3):e2500386.

  111. Puppalwar A, Engineer R, Jha AK, Gudi S, Krishnartry R, Nayak P, Agarwal JP, Goda JS (2026). MRI based radiomics as an imaging biomarker for locally advanced carcinoma rectum: Predicting tumor response following neoadjuvant chemoradiotherapy as an organ preservation strategy. Cancer Reports .9(5):e70574.

  112. P Aswathy, Kannusamy S, Oak A, Prakash G, Joshi A, Murthy V, Menon S, Cheulkar S, Lokhande M, Balasubramaniam G, Dikshit R, Chaturvedi P, Gupta S (2026). Survival outcomes in prostate cancer patients treated at an Indian tertiary care centre. BJUI Compass. ;7(2):e70155. PMID: 41658335

  113. Panzade G, Mahajan AA, Panda SP, Chowdhury U, Iyer RK, Ghosh S, Koley M, Bhattacharya A, Chatterjee A, Dey A, Sarkar C, Chowdhury A, Chatterjee B, Das S, Das S, Bandyopadhyay S, Rajendran RL, Gangadaran P, Ahn BC, Jha SK (2026). Emerging nanoimmunotherapeutic strategies for breast cancer. Discovery Oncology. PMID: 41933234

  114. Patil V, Shah P, Mahajan A, Sable N, Shukla A, Bornak G, Rane S, Gurav S, Ghosh- Laskar S, Pantvaidya G, Janu A, Ankathi S, Sahu A, Bhattacharya A, Vaish R, Tuljapurkar V, Patil A, Bal M, Prabhash K, Noronha V, Menon N, Patil V, Chaturvedi P (2026). Decoding osteoradionecrosis of the jaw: Radiological progression and a novel CT-based grading System. Cancers. 18(2):187. PMID: 41595110

  115. Pullat GB, Bohrmann B, George GS, Dikshit S, Singh A, Chaturvedi P, Dikshit R, Lewington S, Mhatre S (2026). The impact of tobacco cessation on buccal mucosa cancer risk: A multi-centre case-control study in India. International Journal of Cancer. 159(2):368-377.PMID: 41657059

  116. Punde RN, Kshirsagar D, Shinde PH, Darekar K, Chaudhari L, Laskar S. Evaluation of revised TRS398 dosimetry protocol for pencil beam scanning proton therapy systems. Biomedical Physics & Engineering Express. PMID: 42372771.

  117. Pillai A, Ramaswamy A, Rao AR, Kumar A, Mittal K, Sehgal A, Dhekale R, Pawar A, Shetake A, Mahajan S, Daptardar A, Sonkusare L, Deodhar J, Ansari N, Vagal M, Mahajan P, Timmanpyati S, Nookala M, Gota V, Banavali SD, Prabhash K, Noronha V (2026). Screening for poor muscle strength in older Indian patients with solid tumor using SARC-F questionnaire and handgrip. Journal of Geriatric Oncology.

  118. Pal D, Govil D, Pachisia AV, Soni KD, Gupta S, Kothekar AT, Clerk AM, Srinivasan S, Kumar V, Gurav SK, Patel R, D'Costa PM, Prajapati AM, Shelgaonkar J, Karanth S, John JK, Toraskar K, Patel SJ, Savio RD, KN J, Harne R, Pandit RA, Mishra RC, Pande RK, Samavedam S, Singh YP, Myatra SN, Bhattacharya PK, Jagiasi BG, Jose C. Practice pattern of critical care ultraSonography in India (POCUS India): A multicenter cross-sectional survey. Indian Journal of Critical Care Medicine. 30 (5): 398-407.

  119. Patwardhan R, Rizvi Z, Gota V, Checker R, Singh B, Maurya D, Pal D, Ramani N, Kumar BK, Purohit V, Mathapati BS, Mullick J, Ghanty T, Gupta S, Joshi M, Madki S, Awasthi A, Sandur S, Sharma D (2026). First-in-human clinical trial of high-dose sodium copper chlorophyllin: Pharmacology and efficacy as a dual immunomodulatory/antiviral agent. Phytomedicine. 150: 157689. PMID: 41453293

  120. Prakash D, Rangarajan V, Kumar M (2026). A Resource-Efficient End-to-End Multimodal AI Framework for Automated PET-CT Report Generation and TNM Staging in Breast Cancer. Indian Journal of Nuclear Medicine.41:481-98.

  121. Prakash D, Kulkarni P, Rangarajan V, Kumar M (2026). Context-Grounded PET-CT Report Generation Using LoRA-Fine-Tuned BioMedLM with Physician Validation and Safety Evaluation.Indian Journal of Nuclear Medicine.41:461-80

  122. Patkar S, Shah TM, Kazi M, Kannan S, Varty G, Ostwal V, Ramaswamy A, Bhargav P, Barve P, Goel M(2026). Development and validation of nomogram predicting survival in resectable gallbladder cancer. Journal of Hepato-Biliary-Pancreatic Sciences

  123. Pradhan P, Chaudhary T, Mishra S, Konik P, Durinova E, Tuma R, De A, Sinha D (2026). MCJ modulates mitochondrial ETC flux to promote lipid metabolism-driven enhancement of cell proliferation and migration. Cell Death and Disease.

  124. Roy A, Jain N, Pokale R, Madhusoodanan G, Mukharya A, Farhana S, Rao, B Goda JS, Mutalik S (2026). Synergizing immunity: lipid nanoparticle-mediated mRNA and gene delivery as a next-gen paradigm in cancer immunotherapy, International Journal of Pharmaceutics,

  125. Rai P, Janu AK (2026). From Opportunistic Chest CT to Predictive Radiology in MESA: An Early Career Perspective. Radiology. 320(3):e262439.

  126. Redhu AK, Gota V (2026). Ethnopharmacology in contemporary cancer research: Systems perspectives and translational opportunities. Systems Ethnopharmacology and Sustainable Bioresources.

  127. Rai B, Gupta A, Srinivasa GY, Tharavichitkul E, Lowanichkiattikul C, Khine A, Aung YM, Sagpao C, Munandar A, Giselvania A, Jabeen H, Ohno T, Kim JY, Bayasgalan U, Srivastava SK, Chitapanarux I, Chopra S. Palliative care practices in gynecological cancers in asian countries-A cross-sectional survey by the federation of asian organizations for radiation oncology. Journal of Palliative Medicine. 29(1):52-61. PMID: 41020734

  128. Rajendran RL, Mahajan AA, Muthu S, Rajappan Chandra SK, Gangadaran P, Ahn BC. Global Research Trends in Extracellular Vesicle-Based Therapy for Regenerative Medicine: A Bibliometric Analysis (2014-2024). Bioengineering (Basel). 2026 Feb 20;13(2):247. doi: 10.3390/bioengineering13020247. PMID: 41749786; PMCID: PMC12937803

  129. Raveendran V, Sinha S, Mukherjee P, Kumar A, Shinde PH, Prabu AC, Punde RN, Chaudhari LN, Mathew SM, Mohanty S, Swain M, Budrukkar A, Ghosh Laskar S(2026) Exploring the need for plan adaptation in robustly optimized head and neck intensity modulated proton therapy: A dosimetric perspective from initial institutional experience. Clinical Oncology. 56:104216

  130. Redhu AK, Gadewal N, Gota V (2026). Targeting IDH1 (R132H)-Driven Oncometabolic Vulnerabilities: Structure-Guided Discovery of Phytochemical Inhibitor. In Silico Research in Biomedicine. 2:100442

  131. Roy R, Ria T, Das K, Patial V, Das G, Ugir Hossain Sk (2026). A Rationally Engineered Norfloxacin-Phenoxazine Hybrid as a Dual-Function Anticancer Agent: DNA Intercalation Synergizes with Topoisomerase II Inhibition against Murine Breast Tumor. ACS Medicinal Chemistry Letters. 17(8):1678-1690.

  132. Rajpal S, Chatterjee G, Bhanshe P, Terse V, Joshi S, Chaudhary S, Shetty D, Mohanty P, Dhamne C, Tembhare PR, Srinivasan S, Chichra A, Moulik NR, Banavali S, Gujral S, Narula G, Subramanian PG, Patkar N (2026). Clinical Relevance of Genomics Defined WHO5 Subtypes of Pediatric B-ALL in the Context of Measurable Residual Disease-Directed Risk-Based Therapy. JCO Global Oncology.;12(9):e2500665

  133. Reddy M, Mantri M, Kumar V, Bindu A, Mokhale K, Jaiswal D, Mathews S, Shankhdhar VK (2026). Feasibility of Flexor Hallucis Muscle-Based Fibula Bone Segment for Ramus Reconstruction in Head and Neck Cancers. Microsurgery. 46(4):e70245

  134. Raj JAT, Shinde I, Chatterjee A, Ghanekar S, Gadewal N, Chandrani P, Goda J (2026). Virtual screening, Molecular Dynamics, and Density Functional Theory Identify Piperolein A as a Putative Dual PPARα/γ Modulator Relevant to Radiation-Induced Cognitive Decline. ChemistrySelect 11(30) :e74090.

  135. Siddiqui A, Dhandapani H, Rather A, Ingle A, Sharma D, Tayalia P (2026). In situ programming of CAR-macrophages via a polyplex nanomaterial and STING activation for triple-negative breast cancer immunotherapy. Nanoscale.

  136. Shetty C, Singhavi HR, Nair S (2026). Gingivobuccal Cancers: Demographics and Geographic Variations. Oral and Maxillofacial Surgery Clinics of North America.

  137. Sachdev S, Cheloha RW (2026). Multivalent antibody-based conjugates as new tools for tailored modulation of G protein-coupled receptors. British Journal of Pharmacology.

  138. Sable S, Wadasadawala T, Kannan M, Sarin R, Pathak R, Krishnamurthy R, Gulia S, Joshi S, Popat P, Shet T (2026) Validation of Onco-MPI and Geriatric-8 for predicting 2-year mortality in older Indian patients with breast cancer: A prospective observational study. ecancer. 20:2099.

  139. Sarade M, Das D, Mhamane S, Bhojane S, Patil S, Banavali S, Prakash G, Budukh A (2026) Long-term overall survival of testicular cancer: findings from a rural population-based cancer registry, Ratnagiri district, Maharashtra state, India ecancer 20: 2080

  140. Sharma A, Pandey P, Upadhya S,Pushpam D, Khurana S, Devi G, Kumar S, Jain D, Pramesh CS, Jiwnani S, Tembhare P, Biswas S, Kissick H, Nasti T, Ahmad R, Ramalingam S, Singla N, Singh Malik P (2026) .Advancements and perspectives of neoadjuvant immunotherapy in resectable non-small cell lung cancer. Current Problems in Cancer. 63:101311

  141. Singh R, Budukh A, Kolekar S,Kumar G, Qayyumi B, Gupta T, Fatima ZH, Padvi N, Shivashankar S, Shah A, Gupta D, Kumar N, Prabhash K (2026) Profile of cancer cases at a rural cancer centre: insights from Homi Bhabha Cancer Hospital and Research Centre, Muzaffarpur, Bihar, India ecancer 20: 2213

  142. Saha S, Trivedi B, Ojha S, Ambulkar R, Nambiar A, Sarwade K, Kumar A, Kannan S (2026). Towards rational blood utilization: development of a transfusion risk prediction tool for onco-surgical practice. World Journal of Surgical Oncology

  143. Sandbhor P, Goda J, Banerjee R, Dyawanapelly S (2026).Targeted dual-drug delivery for minimal residual glioblastoma using multifunctional thermosensitive liposomal hydrogels. Journal of Drug Delivery Science and Technology.

  144. Sinha S, Ghosh Laskar S, Dhingra S, Kumar A, Mohanty S, Budrukkar A, Swain M, Bishnu PN, Joy I, Ali R, Kannan S, Mummudi N (2026). Avoiding adjuvant Prophylactic Neck irradiation in lateralized oral cavity cancer (APRON). Clinical Oncology. 49: 103980

  145. Subramani V, Chauhan, H, David S, Maitre P, Menon S, Joshi A, Misra A, Arora A, Pal M, Prakash G, Murthy V (2026). Efficacy and safety of adjuvant radiotherapy in primary resected adrenocortical carcinoma – A comparative study. Journal of UroOncology 1(1): 24-30.

  146. Saha P, Varyani R, Hole A, Joshi P, Waghmare MS, Singh A, Chaturvedi P, Govekar R, CM Krishna (2026). Multimodal serum profiling for early detection and risk assessment of oral potentially malignant disorders and oral cancer. Analytical Chemistry.

  147. Suthahar T, Veerabhadrappa J, Munshi R, Anbu Raj E, Gota V, Ivaturi V, Mallayasamy S (2026). Factors influencing pharmacokinetics of 5-fluorouracil in cancer patients: a systematic review of population pharmacokinetic models. European Journal of Clinical Pharmacology. 82(5):126.

  148. Shenoy V, Kannan S, Noronha V, Prabhash K, Ostwal V, Bhargava P, Pillai A, Shamseeya K, Shetake A, Dhekale R, Chitre A, Gota V, Mahajan S, Daptardar A, Sonkusare L, Deodhar J, Ansari N, Vagal M, Mahajan P, Nookala M, Banavali SD, Ramaswamy A (2026). Development of a new model for prediction of relevant treatment related adverse events in older individuals with gastrointestinal cancers. Journal of Geriatric Oncology. 17(2):102817.

  149. Sahu A, Mehta D, Dasgupta A, Dev I, Puranik A, Bhattacharya K, Sahay A, Sridhar E, Shetty P, Moiyadi A, Menon N, Chatterjee A, Gupta T (2026). Patterns of radiation-induced subependymal enhancement in patients with high-grade glioma. Neuroradiology Journal.

  150. Sundararajan R, Harish M, Cherusserikkaran Anthony M, Christie J, Jaiswal D, Venkatraman P (2025). Within and beyond the boundaries of proteasomal assembly: PSMD9 chaperone as a multifunctional protein. Essays in Biochemistry. 69(5):EBC20253044.

  151. Singh M, Ghosh S, Katdare A, Agrawal A, Choudhury S, Phurailatpam R, Patil D, Anaz M, Rangarajan V, Maitre P, Murthy V (2026). PSA and PSMA kinetics after PSMA-PET & MR guided prostate SBRT with focal boost: Results from the phase II PROBE trial. International Journal of Radiation Oncology, Biology, Physics.

  152. Sen S, Mohanty S, Wadasadawala T, Maiti S (2026). The extent of indebtedness among breast cancer survivors in India: A prospective longitudinal study from a tertiary cancer hospital. Journal of Cancer Policy.

  153. Sakhare N, Kumar D, Das S, Mitra A, Mirapurkar S, Rani G, Sheela M, Chirayil V, Mohanty B, Mathur A, Mallia MB, Chaudhari P. Synthesis, radiochemical characterization, and biodistribution of a 188Re analogue of [131I]mIBG in a neuroblastoma xenograft model. J Labelled Comp Radiopharm. 69(3):e70025. PMID: 41844275.

  154. Sakhare N, Muralidharan S, Kumar D, Dutta S, Gnanasekar R, Paradkar S, Mitra A, Mohanty B, Mirapurkar A, Mathur A, Chaudhari P, Bose K (2026). Synthesis and evaluation of 99mTc essential analogue of DUPA PSMA inhibitor for its potential use in prostate cancer imaging. ChemistrySelect. 11(21): e06967.

  155. Shafiq N, Kumar A, Cherian JJ, Madan T, Kshirsagar N, Mukherjee A, Vij S, Singh PK, Srivastava G, Visala A, Kumar A, Soman A, Kotakonda HK, Joglekar S, Joshi M, Udupa V, Poomali A, Noronha NB, Gogtay N, Krishnamurthy MN, Mohapatra S, Saha N, Gota V, Pradhan AK, Chatterjee P, Kumar A, Chaturvedi A, Balasundaram MK, Prakash G, Kakkar AK, Malhotra S (2026). Regulatory and ethical frameworks for first-in-human clinical trials in India: Proceedings of a codesigned capacity-building workshop. Clinical Drug Investigation.PMID: 42189405

  156. Sharma A, Garale M, Lila A, Chakrabarty N, Badhe P, Patil V, Thakkar H, Memon S, Pantvaidya G, Bal M, Barnabas R, Karlekar M, Pai T, Sathe P, Fernandes G, Bandgar T (2026). Diagnostic Performance of Parathyroid CT and CT-Guided Targeted Parathyroidectomy in MEN1-Associated Primary Hyperparathyroidism, Annals of Endocrinology.

  157. Shinde A, Ahire S, Ingle A (2026). Diagnosis of naturally occurring Klebsiella pneumoniae in rodent colonies using conventional, PCR and DNA sequencing method: A Case Report. Journal of Laboratory Animal Science. 9(2): 18-24.

  158. Shinde P, Ak A, Agarwal P, Kamalnath J, Joshi K, Prajapati K, Jain J, Mulani J, Gupta A, Mittal P, Sawant P, Agarwal JP, Cozzi L, Chopra S (2026). Spatially fractionated radiotherapy using straight and bending virtual rods as an alternative for cervical cancer brachytherapy: results from preclinical in-silico dose comparison and quality assurance. British Journal of Radiology.PMID: 42179164

  159. Singh AG, Mahajan A, Sinha S, Shetty R, Mohanty S, Kumar A, Chakrabarty N, Joshi P, Nair S, Laskar SG, Prabhash K, Chaturvedi P (2026). Tumour growth kinetics and stage progression during treatment delay in oral squamous cell carcinoma. Oral Oncology. 179: 108033.PMID: 42190340

  160. Singh P, Thaker K, Gundeti M, Redhu AK, Dighe D, Reddy G, Gota V (2026). Symposium proceedings on 'Samaakalan: The Ayush integration into modern medicine in health and disease'. Journal of Ayurveda and Integrative Medicine. 17(1):101289.PMID: 41650728

  161. Sukumaran B, Xavier RM, Vs Aswathy, Sharumathi M , Rajamohamed H, Arun KP, Deepalaskhmi M (2026). Beyond the Forest Plot: Redefining Model-Based Meta-Analysis as a Quantitative Engine for Model-Informed Drug Development. Drug Development Research. 87(1):e70227. PMID: 41536205.

  162. Surve B, Dewanji C, Khanna A, Saha S, Ojha S (2026). When technology falters: Ensuring donor safety and system reliability amid apheresis technical challenges. Artificial Organs. PMID: 41536147

  163. Singh AG, Kole L, Sullivan R, Sinha S, Shetty R, Joshi P, Nair S, Laskar SG, Prabhash K, Chaturvedi P (2026). Disparity in the Markers of Affordability Across Targeted- and Immune-Therapy Drugs Used in Head and Neck Cancers. Head Neck.

  164. Sundaravadivelu PK, Raina K, Borthakur A, Mahto P, Shetty D, Dhamne C, Kaveeshwar V, Martin CA, Radhakrishnan S, Rela M, Thummer RP (2026). Derivation and characterization of the iPSC line IITGi001-B from primary human adult dermal fibroblasts. Stem Cell Research.

  165. Teja M, Berenguer Frances MA, López Campos F, Feltes Benítez N, Stoica A, Puertas A, Marvaso G, Murthy V, Couñago F (2026). The Role of SBRT in oligometastatic prostate cancer: Where we are and where we are heading. Life (Basel).

  166. Tambe M, Rajak J, Karale B, Firfire A, D'Silva SZ. Identification of the Novel HLA-B Allele, HLA-B*37:122, in an Individual From Western India. HLA. 2026 Mar;107(3):e70629. doi: 10.1111/tan.70629. PMID: 41742837.

  167. Terlizzi M, Ploussard G, Fiard G, Murthy V, Ost P, Zilli T, Zamboglou C, Blanchard P, Sargos P. Re-evaluating Biochemical Recurrence Definitions After Radiation Therapy: Time to Move Beyond "Phoenix"? International Journal of Radiation Oncology Biology Physics. 125(3):875-877. PMID: 42259321.

  168. Tambe M, Rajak J, Karale B, Firfire A, D'Silva SZ. Identification of the Novel HLA-B Allele, HLA-B*37:122, in an Individual From Western India. HLA. 2026 Mar;107(3):e70629. doi: 10.1111/tan.70629. PMID: 41742837.

  169. Tshering P, Tshomo U, Chetri M, Suberi S, Yangdon Y, Dzed L, Lhadon T, Bagal S, Mhamane S, Budukh A (2026). Cancer pattern in Bhutan (2014-2022): Findings from population-based cancer registry- A pathway to monitor cancer control activities. International Journal of Cancer.158(11):2829-2840. PMID: 41634951

  170. Trikha M, Rath S, Ventrapati P, Bhargava P, Siddiqui A, Pawar A, Patil P, Krishnamurthy R, Sahay A, Popat P, Haria P, Shah S, Kapu V, Sekar A, Pathak R, Joshi S, Wadasadawala T, Sarin R, Badwe R, Gupta S, Bajpai J (2026). Self-Reported Compliance with Adjuvant Endocrine Therapy in Young Women with Hormone Receptor-Positive Early Breast Cancer: A Real-World Study from a Tertiary Cancer Centre in India. Clinical Breast Cancer

  171. Tambe M, Firfire A, D'Silva SZ (2026). A Novel Exonic Variant MICB*075 Was Identified in an Individual From Maharashtra, India. HLA. 108(3):e70965

  172. Thapa B, Fatima E, Gupta A, Shukla E, Verma D, Singh A, Parashar S, Sarita, Bawankule D, Khan F, Chanda D, Kode J, Negi A (2026). Benzofluorene derivative exhibits antiproliferative effect against leukemia by tubulin polymerisation inhibition. Sustainable Chemistry One World.

  173. Valle L, Romero-Kalbasi T, Jiang T, van Dams R, Fuller D, Loblaw A, Kennedy T, Collins S, Sharma V, Suy S, Murthy V, Mallick I, Nickols N, Desai N, Hannan R, Aghdam N, Kaplan I, Stephans K, Tendulkar R, Lau S, Taparra K, Steinberg M, Kishan A (2026). Extended fllow-up from the stereotactic body radiotherapy for high-risk localized carcinoma of the prostate (SHARP) consortium: Updated analysis of 440 patients. European Urology Oncology,

  174. Verma A, Hoysal DR, Deshpande A, Badwe R (2026).Letter to the Editor “Adjuvant ovarian function suppression and aromatase inhibitors in premenopausal patients with hormone receptor–positive, HER2-positive breast cancer”. The Breast.86:104716. PMID: 41644336

  175. Vatsa P, Chaudhary B, Kamble A, Waghmare S, Sharma S, Mandoli A (2026).Disrupting microtubule dynamics to rewire apoptosis, differentiation, and EMT programs in oral squamous cell carcinoma through indenamine derivatives. Bioorganic & Medicinal Chemistry.132:118444

  176. Wintner LM, Sztankay M, Abdel-Razeq H, Hamdan-Mansour R, Caocci G, Mouillet G, Kikawa Y, Shibata N, Krishnamurthy MN, Joshi A, Krishnatry R, Jain A, Pappot H, Petranović D, Trobentar A, Schmidt H, Schulze S, Tararykova A, Zabernigg A, Giesinger JM, Holzner B; EORTC Quality of Life Group. Inter-rater reliability of CTCAE assessments with or without EORTC patient-reported outcome data in a mixed cancer population: a multinational, open-label, randomised controlled trial. Lancet Oncology. 27(2):233-242. PMID: 41570841.
  177. Yegnaswamy S, Selvaa Kumar C, Aldaais E, Shinde I (2026). Structural resilience of conserved-site mutations in the MERS-CoV membrane protein: insights into stability and conformational dynamics. Journal of Biomolecular Structure and Dynamics.

  178. Zeineldin M, Murry JB, Shetty D, Middlezong W, Parish R, Xiao Z, Cui C, Li P, Wen J, Tang G, Zou YS (2026). Acquired ring chromosomes in hematological malignancies: A systematic evidence review for diagnostic advances, cytogenomic insights, and clinical significance by an International Consortium on Human Ring Chromosomes (ICHRC) working group. Cancer Genetics. ;306-307:69-90. PMID: 42263477.

  179. Zilli T, Zaorsky N, Maitre P, Desai N, Seibert T, Sun Y, Dess T, Tree A, Koontz B (2026). Metastasis-directed Therapy in Oligometastatic Castration-resistant Prostate Cancer: From Chasing the Last Metastasis to Changing the Game?International Journal of Radiation Oncology,Biology,Physics. 125 (1): 11-14.PMID: 42000353

Category
International
Select Year
2026
order
8
Back to Top